http://www.unboundmedicine.com/medline/ebm/research/insulin_glargineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19894270/full_citation/Reestablishment_of_the_nasal_permeability_barrier_to_several_peptides_following_exposure_to_the_absorption_enhancer_tetradecyl_beta_D_maltoside_Arnold JJ, Fyrberg MD, Meezan E, et al. 
Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside. [JOURNAL ARTICLE]
J Pharm Sci 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19893914/full_citation/[Use_of_insulin_glargine_in_type_1_diabetes_children_with_less_than_eight_years_old]Rollin G, Punales M, Geremia C, et al. 
[Use of insulin glargine in type 1 diabetes children with less than eight years old] [English Abstract, Journal Article]
Arq Bras Endocrinol Metabol 2009 Aug; 53(6):721-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19883893/full_citation/Insulin_Glargine_Induced_Persistent_Intractable_Hypoglycemia_with_Variable_Presentations_in_Older_Diabetic_Patients:_An_Experience_of_4_Cases_Kumari J, Dharmarajan TS 
Insulin Glargine Induced Persistent Intractable Hypoglycemia, with Variable Presentations in Older Diabetic Patients: An Experience of 4 Cases. [LETTER]
J Am Med Dir Assoc 2009 Nov; 10(9):672-673.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19875618/full_citation/Insulin_glargine_controversy:_a_tribute_to_the_editorial_team_at_Diabetologia_Butler PC 
Insulin glargine controversy: a tribute to the editorial team at Diabetologia. [Editorial]
Diabetes 2009 Nov; 58(11):2427-8.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19859691/full_citation/Diabetes_treatment_with_insulin_glargine_and_risk_of_malignancy:_methodological_pitfalls_and_ethical_issues_Simon D 
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues. [JOURNAL ARTICLE]
Diabetologia 2009 Oct 27.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19838665/full_citation/No_evidence_of_increased_risk_of_malignancies_in_patients_with_diabetes_treated_with_insulin_detemir:_a_meta_analysis_Dejgaard A, Lynggaard H, Råstam J, et al. 
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. [JOURNAL ARTICLE]
Diabetologia 2009 Oct 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19834874/full_citation/Nocturnal_Blood_Glucose_and_IGFBP_1_Changes_in_Type_1_Diabetes:_Differences_in_the_Dawn_Phenomenon_between_Insulin_Regimens_Yagasaki H, Kobayashi K, Saitou T, et al. 
Nocturnal Blood Glucose and IGFBP-1 Changes in Type 1 Diabetes: Differences in the Dawn Phenomenon between Insulin Regimens. [JOURNAL ARTICLE]
Exp Clin Endocrinol Diabetes 2009 Oct 15.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_Strojek K, Bebakar WM, Khutsoane DT, et al. 
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19809025/full_citation/Using_effectiveness_and_cost_effectiveness_to_make_drug_coverage_decisions:_a_comparison_of_Britain_Australia_and_Canada_Clement FM, Harris A, Li JJ, et al. 
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. [Comparative Study, Journal Article, Research Support, Non-U.S. Gov't]
JAMA 2009 Oct 7; 302(13):1437-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19808914/full_citation/Insulin_Glargine_Safety_in_Pregnancy:_a_Transplacental_Transfer_Study_Pollex EK, Feig DS, Lubetsky A, et al. 
Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study. [JOURNAL ARTICLE]
Diabetes Care 2009 Oct 6.
Abstract | Full Citation